S.2837 - Preventing Drug Diversion Act of 2018115th Congress (2017-2018)
|Sponsor:||Sen. Hassan, Margaret Wood [D-NH] (Introduced 05/14/2018)|
|Committees:||Senate - Judiciary|
|Latest Action:||Senate - 06/19/2018 Placed on Senate Legislative Calendar under General Orders. Calendar No. 471. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: S.2837 — 115th Congress (2017-2018)All Information (Except Text)
Introduced in Senate (05/14/2018)
Preventing Drug Diversion Act of 2018
This bill establishes a new requirement intended to help drug manufacturers and distributors identify and prevent suspicious orders of opioids and reduce rates of diversion.
Specifically, the Drug Enforcement Administration (DEA) must use its automated data system—the Automated Reports and Consolidated Ordering System—to inform drug manufacturers and distributors about the quantity and type of opioids that are distributed to pharmacies and practitioners.
Additionally, the bill establishes new requirements for reporting, collecting, and sharing information about suspicious orders.